Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches; Public Workshop; Request for Comments; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Food and Drug Administration is correcting a notice entitled "Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches" that appeared in the Federal Register of April 24, 2023. The document announced a public workshop. The document was published with an incorrect topic for discussion. This document corrects that error.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 84 (Tuesday, May 2, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 84 (Tuesday, May 2, 2023)]
[Notices]
[Page 27522]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-09206]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2023-N-1259]
Advancing the Utilization and Supporting the Implementation of
Innovative Manufacturing Approaches; Public Workshop; Request for
Comments; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop; request for comments; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration is correcting a notice
entitled ``Advancing the Utilization and Supporting the Implementation
of Innovative Manufacturing Approaches'' that appeared in the Federal
Register of April 24, 2023. The document announced a public workshop.
The document was published with an incorrect topic for discussion. This
document corrects that error.
FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy,
Legislation, and International Affairs, Food and Drug Administration,
301-796-9115, <a href="/cdn-cgi/l/email-protection#35795c46541b7247545b525047755351541b5d5d461b525a43"><span class="__cf_email__" data-cfemail="d599bca6b4fb92a7b4bbb2b0a795b3b1b4fbbdbda6fbb2baa3">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
In the Federal Register of April 24, 2023, in FR Doc. 2023-08545
(88 FR 24807), on page 24808, the following correction is made:
<bullet> On page 24808, in the second column, in Section II,
``Topics for Discussion at the Public Workshop,'' the fifth topic,
``Science- and risk-based approaches for developing and accessing
innovative technologies across platform products and sites to
streamline adoption.'' is corrected to read ``Science- and risk-based
approaches for developing and assessing innovative technologies across
platform products and sites to streamline adoption.''
Dated: April 26, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-09206 Filed 5-1-23; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.